Tech Company Financing Transactions
Cylex Funding Round
Cylex closed a $18.4 million Series C funding round on 12/5/2006. Backers included Canaan Partners and Channel Medical Partners.
Transaction Overview
Company Name
Announced On
12/5/2006
Transaction Type
Venture Equity
Amount
$18,400,000
Round
Series C
Investors
Canaan Partners (Seth Rudnick)
Channel Medical Partners (Carol Winslow)
Proceeds Purpose
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8980 Old Annapolis Rd.
Columbia, MD 21045
USA
Columbia, MD 21045
USA
Phone
Website
Email Address
Overview
Cylex operates as a life sciences company that develops, manufactures, and commercializes in vitro diagnostic products such as ImmuKnow.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Brad Stewart
VP - Customer Service
Sharlene Blum
VP - Human Resources
Dena Meagher
VP - Operations
Marc Berman
VP - Product Management
Jianrong Lou
Browse more venture capital transactions:
Prev: 12/5/2006: ICx Technologies venture capital transaction
Next: 12/5/2006: DigitalPersona venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs